Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Evotec, Haplogen in Infectious Disease Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Evotec, Haplogen in Infectious Disease Pact

Will co-develop drugs against viruses

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Evotec and Haplogen have signed a collaboration agreement to discover and develop small molecules against viral infectious diseases. Financial terms were not disclosed.
 
The companies will co-develop drugs against a human protein that is essential for pathogenic viruses to infect their host cell. This protein was discovered by Haplogen’s technology that identifies host factors for infectious pathogens. Evotec will further develop lead compounds and apply its drug discovery platform to find additional small molecule inhibitors.
 
“This partnership will ensure that our therapeutic program advances with increasing pace to discover molecules for clinical testing in those patients that are at high risk of virus infections,” said Georg Casari, chief executive officer of Haplogen. “We are excited that Evotec shares our vision and has joined forces on this first-in-class drug target.”
 
Mario Polywka, chief operating officer of Evotec, said, “Part of Evotec’s strategy is to pursue innovative, early stage projects and develop them to a partnering position before the clinic. We are delighted to partner with Haplogen to optimize their protein inhibitors. Haplogen’s powerful target discovery technology is an excellent complement to Evotec’s small molecule discovery and development capabilities. We hope that this is the start of a long-term relationship.”
 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics